Literature DB >> 24420854

Side populations from cervical-cancer-derived cell lines have stem-cell-like properties.

Jairo Villanueva-Toledo1, Alberto Ponciano-Gómez, Elizabeth Ortiz-Sánchez, Efraín Garrido.   

Abstract

The target cells for the transforming mutations caused by high-risk human papillomavirus (HPV) infection could be the stem cells of the uterine cervical epithelium, generating particular cancer stem cells (CSCs). The aim of this study was to identify and characterize the CSCs from cervical-cancer-derived cell lines. The ability of SiHa, CaLo, and C-33A cell lines to efflux Hoechst 33342 was evaluated by flow cytometry and cells from the corresponding side populations (SPs) and nonside populations (NSPs) were analyzed for their cell-cycle status (pyronin Y) and their mRNA levels of ABC transporter family members (with qPCR). Specific markers (α6-integrin(bri)/CD71(dim), CK17) of normal epithelial stem cells were evaluated by flow cytometry. The biological properties of these cells were analyzed, including their colony heterogeneity, repopulation, and anchorage-independent colony formation. We identified SPs (around 3 %) in the SiHa and CaLo cell lines, more than 70 % of which were in G0 phase and strongly expressed ABC transporters (predominantly ABCG2 and ABCB1). The SP from CaLo cells showed an α6-integrin(bri)/CD(dim) pattern, whereas the SP from the SiHa cells showed an α6-integrin(-)/CD(dim) pattern. Recultured cells from the SPs of both cell lines generated both SPs and NSPs, and had higher clonogenic potential to form mainly holoclones and greater colony-forming efficiency under anchorage-independent growth conditions than the cells from the NSPs or total cell populations. Interestingly, we identified no SP in the HPV-uninfected C-33A cell line, and it did not express ABCG2 or other members of the ABC transporters (ABCB1, ABCC1, or ABCA3).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24420854     DOI: 10.1007/s11033-014-3047-3

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  12 in total

1.  Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.

Authors:  I Nindl; K Rindfleisch; B Lotz; A Schneider; M Dürst
Journal:  Int J Cancer       Date:  1999-07-19       Impact factor: 7.396

2.  The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype.

Authors:  S Zhou; J D Schuetz; K D Bunting; A M Colapietro; J Sampath; J J Morris; I Lagutina; G C Grosveld; M Osawa; H Nakauchi; B P Sorrentino
Journal:  Nat Med       Date:  2001-09       Impact factor: 53.440

3.  Cancer stem cells are enriched in the side population cells in a mouse model of glioma.

Authors:  Molly A Harris; Hyuna Yang; Benjamin E Low; Joydeep Mukherjee; Joydeep Mukherje; Abhijit Guha; Roderick T Bronson; Leonard D Shultz; Mark A Israel; Kyuson Yun
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

4.  Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis.

Authors:  Albert Santamaria-Martínez; Jordi Barquinero; Anna Barbosa-Desongles; Antoni Hurtado; Tomàs Pinós; Joan Seoane; Marie-France Poupon; Joan Morote; Jaume Reventós; Francina Munell
Journal:  Exp Cell Res       Date:  2009-05-15       Impact factor: 3.905

5.  Quiescent, slow-cycling stem cell populations in cancer: a review of the evidence and discussion of significance.

Authors:  Nathan Moore; Stephen Lyle
Journal:  J Oncol       Date:  2010-09-29       Impact factor: 4.375

6.  Models of neoplasia and their diagnostic implications: a historical perspective.

Authors:  D M Goldberg; E P Diamandis
Journal:  Clin Chem       Date:  1993-11       Impact factor: 8.327

7.  Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance.

Authors:  William Matsui; Qiuju Wang; James P Barber; Sarah Brennan; B Douglas Smith; Ivan Borrello; Ian McNiece; Lan Lin; Richard F Ambinder; Craig Peacock; D Neil Watkins; Carol Ann Huff; Richard J Jones
Journal:  Cancer Res       Date:  2008-01-01       Impact factor: 12.701

8.  The search for cancer stem cells in hepatocellular carcinoma.

Authors:  Yukio Kamohara; Naotsugu Haraguchi; Koshi Mimori; Fumiaki Tanaka; Hiroshi Inoue; Masaki Mori; Takashi Kanematsu
Journal:  Surgery       Date:  2008-08       Impact factor: 3.982

9.  Functional analyses of the cancer stem cell-like properties of human endometrial tumor initiating cells.

Authors:  Anne M Friel; Petra A Sergent; Christine Patnaude; Paul P Szotek; Esther Oliva; David T Scadden; Michael V Seiden; Rosemary Foster; Bo R Rueda
Journal:  Cell Cycle       Date:  2007-10-24       Impact factor: 4.534

10.  Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.

Authors:  M A Goodell; K Brose; G Paradis; A S Conner; R C Mulligan
Journal:  J Exp Med       Date:  1996-04-01       Impact factor: 14.307

View more
  9 in total

Review 1.  Cancer Stem Cells and Their Possible Implications in Cervical Cancer: A Short Review.

Authors:  Riccardo Di Fiore; Sherif Suleiman; Rosa Drago-Ferrante; Yashwanth Subbannayya; Francesca Pentimalli; Antonio Giordano; Jean Calleja-Agius
Journal:  Int J Mol Sci       Date:  2022-05-05       Impact factor: 6.208

2.  Cervical cancer stem cells manifest radioresistance: Association with upregulated AP-1 activity.

Authors:  Abhishek Tyagi; Kanchan Vishnoi; Harsimrut Kaur; Yogesh Srivastava; Bal Gangadhar Roy; Bhudev C Das; Alok C Bharti
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

3.  HPV16-E2 protein modifies self-renewal and differentiation rate in progenitor cells of human immortalized keratinocytes.

Authors:  Victoria Domínguez-Catzín; Alicia-María Reveles-Espinoza; Janet Sánchez-Ramos; Raúl Cruz-Cadena; Diana Lemus-Hernández; Efraín Garrido
Journal:  Virol J       Date:  2017-04-03       Impact factor: 4.099

4.  Wnt/β‑catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer (Review).

Authors:  Gui-Xian Zhu; Dian Gao; Zhao-Zhao Shao; Li Chen; Wen-Jie Ding; Qiong-Fang Yu
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

Review 5.  Human papillomavirus induced transformation in cervical and head and neck cancers.

Authors:  Allie K Adams; Trisha M Wise-Draper; Susanne I Wells
Journal:  Cancers (Basel)       Date:  2014-09-15       Impact factor: 6.639

6.  Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression.

Authors:  Elizabeth Ortiz-Sánchez; Luz Santiago-López; Verónica B Cruz-Domínguez; Mariel E Toledo-Guzmán; Daniel Hernández-Cueto; Saé Muñiz-Hernández; Efraín Garrido; David Cantú De León; Alejandro García-Carrancá
Journal:  Oncotarget       Date:  2016-05-31

Review 7.  Cancer stem cells (CSCs), cervical CSCs and targeted therapies.

Authors:  Ruixia Huang; Einar K Rofstad
Journal:  Oncotarget       Date:  2017-05-23

8.  The role of NF-κB and miRNA in oral cancer and cancer stem cells with or without HPV16 infection.

Authors:  Nasreen Bano; Manisha Yadav; Dheeraj Mohania; Bhudev C Das
Journal:  PLoS One       Date:  2018-10-29       Impact factor: 3.240

Review 9.  Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies.

Authors:  Vaishnavi Muralikrishnan; Thomas D Hurley; Kenneth P Nephew
Journal:  Cancers (Basel)       Date:  2020-04-13       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.